Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice. - Wikidata - awgldk - TriplyDB

Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice.

Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice.

http://www.wikidata.org/entity/Q39191329

about

Generation and 3-Dimensional Quantitation of Arterial Lesions in Mice Using Optical Projection Tomography.Novel biomarkers for cardiovascular risk prediction.Galectin-3 in Peripheral Artery Disease. Relationships with Markers of Oxidative Stress and Inflammation.B cells and humoral immunity in atherosclerosis Modified citrus pectin inhibits galectin-3 function to reduce atherosclerotic lesions in apoE-deficient mice.Galectin-3, a biomarker linking oxidative stress and inflammation with the clinical outcomes of patients with atherothrombosis.Comparison of galectin expression signatures in rejected and accepted murine corneal allografts.Galectin-3 deficiency exacerbates hyperglycemia and the endothelial response to diabetes.Low or No Inhibitory Potency of the Canonical Galectin Carbohydrate-binding Site by Pectins and Galactomannans Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke.Advanced glycation end-products: a common pathway in diabetes and age-related erectile dysfunction.Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis.Galectin-3: an emerging all-out player in metabolic disorders and their complications.Krüppel-like Factor 3 (KLF3/BKLF) Is Required for Widespread Repression of the Inflammatory Modulator Galectin-3 (Lgals3).Labeling galectin-3 for the assessment of myocardial infarction in rats.Soluble galectin-3 is associated with premature myocardial infarction.Galectin-3 is a regulator of metaflammation in adipose tissue and pancreatic islets.Galectin-3 alters the lateral mobility and clustering of β1-integrin receptors.Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review).Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update.Galectin-3: an emerging biomarker in stroke and cerebrovascular diseases.Genetic Variants in the Vicinity of LGALS-3 Gene and LGALS-3 mRNA Expression in Advanced Carotid Atherosclerosis: An Exploratory Study.

P2860

Q30403917-F4C81CE4-8E1C-47C8-8626-3882CFFF0AE7 Q33615459-95AB5FD8-7076-4B06-82FC-1E2BFBBD1039 Q33754984-0586DA68-CB80-492C-85BC-C4478BF80517 Q33789638-33370CC5-EA0D-4453-89A1-8FB8469CB6B4 Q33828006-62264A22-F64B-45A8-B7B2-C8C3FC6E1B34 Q35026202-0797E085-BF71-4934-A79B-1CB15E763582 Q35602405-FC50A76E-2D40-4656-B859-8EC5BB965DE2 Q35842591-9508B629-F291-4202-9C0E-2EECC1C5C883 Q37065931-5ED85390-9176-4766-AAAA-B427EE5E3471 Q37599836-3F4928A3-77E4-4B1A-BC10-8D98FAB06DBA Q38118993-C53AEC7B-3D32-4E34-BE92-B0B69569D65E Q38232998-72133725-5421-4D70-BB0D-CFF2F7F8C10B Q38258947-A6DD8ADC-0103-49E8-BACA-3C8464E1FEEC Q38862296-4DAAFE6A-340A-4804-95D4-5B8E25A1089E Q40792117-8FFFDBB8-8BD7-49A8-876C-DB4514473876 Q40908249-0359564D-A37E-432B-A47F-3BF4E30C5D05 Q42624178-44EE4C9A-61F4-469A-A02E-860F8DDF8FAD Q42706786-F7D6B134-BC75-439A-85BD-68509C256C69 Q47329197-92E815E2-EB93-4CD3-A458-D22C10DCFC75 Q47653100-8A9F3CEB-F7D8-41AD-897C-D335D8491EE5 Q47733264-0FE0B3ED-05F2-4822-B10C-6B219351439F Q51746575-86813A9F-F8F8-444A-AB64-5A440C14501D

P2860

Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice.

http://www.wikidata.org/entity/Q39191329

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice.

@en

Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice.

@nl

type

label

Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice.

@en

Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice.

@nl

prefLabel

Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice.

@en

Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice.

@nl

P1433

Q39191329-EEE441C8-206B-48DB-AF00-1234D03ACDE8

P1476

Q39191329-C851DC5D-E756-48DD-AFDD-8EA9AC797081

P2093

Q39191329-08BC2E42-13F0-4629-BDEC-ECD24C83B524

Q39191329-6A0AA414-C603-43A1-B273-75200B6811D5

Q39191329-9E4D953A-89AD-4BB9-B726-78A093D88E29

Q39191329-9FA53782-E4DE-4CEB-847E-7EA9767FAD32

Q39191329-B0B6EAF3-A5C6-4C4E-97D8-CDDEA8D5FF0D

Q39191329-B5B479EB-0A87-4A18-8734-EEF0DBB8DA49

P2860

Q39191329-0CD381BC-E5C7-4D3A-83B2-172C83B45299

Q39191329-10630405-84C3-4F3F-A29D-D0A661DB622B

Q39191329-136E1E67-897D-4283-BB70-2990AB011C81

Q39191329-14B61E78-5467-477B-8E45-22429250AA44

Q39191329-1A57B9AF-B7D4-47BE-959E-DD9458BF2351

Q39191329-20C2878A-103F-4DC0-8D93-E1DE032A2613

Q39191329-231C38DA-3FA8-457D-AA86-1E5B1EBFFF8B

Q39191329-2A3AF691-D26B-410F-9AB2-F48B3FA17199

Q39191329-2CD04541-3E76-4ADB-B510-5DEBB3D75391

Q39191329-2CFB1003-D6B6-4F1F-8443-F386437EFE21

P304

Q39191329-A9F3E494-1278-4788-A2AC-E0DB5F5D9BF8

P31

Q39191329-415F3987-805D-48D2-8DE0-13EFBABDF56B

P356

Q39191329-3F5718C5-F746-4966-A9F4-82AF00387138

P433

Q39191329-26A4AA63-C82D-4670-AE37-B834FB4A7A2C

P478

Q39191329-E9EE0DDA-D737-4ED9-99F6-D7F083275E88

P577

Q39191329-07A88A35-E53E-4696-A070-4D08E2470B3D

P5875

Q39191329-D5A1AA82-FB0F-4EA7-A3E2-15D785EFFBFA

P698

Q39191329-E7D7F311-1DAC-4A2D-A173-2E6FE9C2F760

P921

Q39191329-E842DC69-188A-402F-9EF4-25E798F02BB0

P932

Q39191329-061BC675-835A-43B6-8AF0-08C1A657F8EC

P356

P1433

P1476

Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice.

@en

P2093

Alison C MacKinnon

http://www.w3.org/2001/XMLSchema#string

David E Newby

http://www.w3.org/2001/XMLSchema#string

Mark R Miller

http://www.w3.org/2001/XMLSchema#string

Patrick Wf Hadoke

http://www.w3.org/2001/XMLSchema#string

Tariq Sethi

http://www.w3.org/2001/XMLSchema#string

Xiaojun Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Human galectin-3 is a novel chemoattractant for monocytes and macrophages

Interleukin-4 regulates connective tissue growth factor expression in human lung fibroblasts

Galectin-3 regulates myofibroblast activation and hepatic fibrosis

Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3

Modified citrus pectin anti-metastatic properties: one bullet, multiple targets

Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation

Quantitative 3-dimensional imaging of murine neointimal and atherosclerotic lesions by optical projection tomography.

IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice.

P304

654-663

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/GLYCOB/CWT006

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235682309

http://www.w3.org/2001/XMLSchema#string

P698

23426722

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

3641797

http://www.w3.org/2001/XMLSchema#string